Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 23 July 2023 31 July 2024 31 July 2024 15021462 Mr Ramesh Phuyal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15021462 2023-07-22 15021462 2024-07-31 15021462 2023-07-23 2024-07-31 15021462 frs-core:CurrentFinancialInstruments 2024-07-31 15021462 frs-bus:PrivateLimitedCompanyLtd 2023-07-23 2024-07-31 15021462 frs-bus:FilletedAccounts 2023-07-23 2024-07-31 15021462 frs-bus:Micro-entities 2023-07-23 2024-07-31 15021462 frs-bus:AuditExempt-NoAccountantsReport 2023-07-23 2024-07-31 15021462 frs-bus:Director1 2023-07-23 2024-07-31
Registered number: 15021462
Ruro Pharm Ltd
Unaudited Financial Statements
For the Period 23 July 2023 to 31 July 2024
Original Accountancy Limited
Balance Sheet
Registered number: 15021462
31 July 2024
£
Fixed assets 1,471
Current assets 1,195
Creditors: Amounts Falling Due Within One Year (341 )
NET CURRENT ASSETS 854
TOTAL ASSETS LESS CURRENT LIABILITIES 2,325
Accruals and deferred income (150 )
NET ASSETS 2,175
CAPITAL AND RESERVES 2,175

Notes

1. General Information
Ruro Pharm Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15021462 . The registered office is 15 Askwith Road, Gloucester, GL4 4PW.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Ramesh Phuyal
Director
20th September 2024